about
May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease?Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's diseaseAn overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levelsInnate immunity in Alzheimer's disease: a complex affairAlzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasisInvolvement of CTR1 and ATP7A in lead (Pb)-induced copper (Cu) accumulation in choroidal epithelial cellsPhysiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators.A review of β-amyloid neuroimaging in Alzheimer's disease.Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells.The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen.HFE gene variants, iron, and lipids: a novel connection in Alzheimer's diseaseSilencing GADD153/CHOP gene expression protects against Alzheimer's disease-like pathology induced by 27-hydroxycholesterol in rabbit hippocampusMultifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugsThalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of InflammationWhy do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agentsPeripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseasesInhibition of tissue transglutaminase promotes Aβ-induced apoptosis in SH-SY5Y cells.Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases.Multifunctional drugs with different CNS targets for neuropsychiatric disorders.Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet.Present and prospective clinical therapeutic regimens for Alzheimer's disease.Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's disorders?Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.Broad DNA repair responses in neural injury are associated with activation of the IL-6 pathway in cholesterol-fed rabbits.Current and future therapy in Alzheimer's disease.Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disordersTissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.Novel drug targets based on metallobiology of Alzheimer's disease.Current perspectives on pharmacotherapy of Alzheimer's disease.Dairy constituents and neurocognitive health in ageing.Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim.Oxidative stress and β-amyloid protein in Alzheimer's disease.Cortical Astrocytes Acutely Exposed to the Monomethylarsonous Acid (MMAIII) Show Increased Pro-inflammatory Cytokines Gene Expression that is Consistent with APP and BACE-1: Over-expression.A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity.Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators.Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice BrainsIron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases.Exposure to As-, Cd-, and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats.
P2860
Q24600533-EAC6BEAC-8DAC-40DE-8E95-24D11674C478Q24651822-42958E2E-A7D3-4828-BF4C-F1D23B1C11B5Q26751302-71676426-3319-4DE2-8E54-8A012258B2B1Q27006944-6DA5D9A1-988D-4CC8-880A-E376A543CE98Q27024824-AEF4FA54-58E3-4763-AC7A-3C0873013CA5Q28567134-3D023C32-43AC-4CCC-8D1E-AC60C0B828FEQ30855088-9E5850C1-2FE5-4BD3-901F-159F5440F986Q30870063-7B80729D-60CF-47F1-970D-DB14CEF2353AQ33323232-3A98A4B6-31A3-479C-A2E7-3E9B3C5339ECQ33790013-685D93D4-44E7-4A55-A85B-55F604023697Q33861622-A04A7D31-E561-4425-AAF3-269F2CC358C2Q34064442-82B75C8F-197C-47FD-B328-4A35174C2B52Q34911093-75E025A1-A67C-40A4-ACDF-EEB2538D3D67Q35121026-DA39CDD3-8A67-4766-8C77-CDB2D0BEF6D3Q35546008-57E98B8C-70D2-4A17-9433-1BB5DD8BD513Q36023238-631FC4EA-62A4-4801-BCAB-554F9902F5C7Q36144015-C21530D1-909E-45A3-BAFE-0576FAC8B89BQ36543057-38D9467B-3837-4BFC-8713-40F0B09CB60DQ36630021-09048895-848F-4BDA-971E-2F13B27F75FCQ36819515-59FFBAF9-D5F1-4EB9-8D83-D62DC365CEE5Q36876447-EF2BB611-11FD-4CD8-B665-0E0FECBA31EBQ36919155-7CE8EB4A-8DB0-4A64-8D89-9A5309DC13B6Q37005143-4B22A893-BF22-492D-A260-53E0792172A9Q37087976-58530AFC-D99E-4E95-8731-167F0305B167Q37165703-7F13BB31-1574-42E2-9FCF-08993DE7D04CQ37249765-A5EB6C6C-DA8B-49F9-A09F-B14DCEA57AB2Q37266151-CE49D6ED-D599-4F90-9552-041D8FED6EE5Q37375005-E3D2FE5C-DBD4-45D1-9F3D-8F007EB3351BQ37376532-C3C573A6-DC7E-49D0-915B-C2AA74836A38Q37799838-B16C6308-CDE7-4BD1-9B53-CAF8FAB3B7F9Q37827489-7CF07326-5703-43DC-BE54-C00F99213308Q37845454-3B12A624-EFD2-4B9E-A0CE-D1F97E37D011Q37848245-CFB643DF-D2C9-4052-918B-D24F9D1EC5CEQ37928994-04F5FBDC-6095-4E98-9B34-7898ABC83EDAQ38763381-886569A9-CBFF-4D4F-999B-4B2CBE05483CQ39748795-580A7FAD-D611-40BA-8A64-37267B6AE5E5Q41599510-9535C5D1-D081-4125-A16A-6740AFE53CE1Q41653816-7B1B5EC0-D11C-4E35-94BA-16F34E1850BEQ42643645-1EDA6CB9-7DFA-4792-8C7B-E3B832F8789BQ42703976-902BFB5F-A29D-40E0-859C-F64CD5B76F69
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Metal and inflammatory targets for Alzheimer's disease.
@ast
Metal and inflammatory targets for Alzheimer's disease.
@en
type
label
Metal and inflammatory targets for Alzheimer's disease.
@ast
Metal and inflammatory targets for Alzheimer's disease.
@en
prefLabel
Metal and inflammatory targets for Alzheimer's disease.
@ast
Metal and inflammatory targets for Alzheimer's disease.
@en
P356
P1433
P1476
Metal and inflammatory targets for Alzheimer's disease.
@en
P2093
Debomoy K Lahiri
Jack T Rogers
P304
P356
10.2174/1389450043345272
P577
2004-08-01T00:00:00Z